Vitamin C IV Therapy — Benefits, Cost and Where to Get It

Vitamin C is one of the most-requested IV ingredients in the entire IV therapy market. At doses orders of magnitude higher than you can absorb orally, IV vitamin C delivers an antioxidant and immune-supporting effect that simply isn''t achievable from supplements or food.

The bioavailability problem with oral vitamin C

Oral vitamin C absorption is capped at roughly 200 mg per single dose. Higher oral doses don''t increase plasma vitamin C meaningfully - the excess is excreted unchanged.

IV administration bypasses this transport limit entirely. Plasma vitamin C concentrations achievable through IV are 30 to 70 times higher than the maximum reachable through oral intake.

Common doses and what they''re used for

Low dose (1,000 to 2,500 mg) - included in most general wellness drips as antioxidant support
Mid dose (5,000 to 10,000 mg) - dedicated immune protocols, used before travel or at first sign of illness
High dose (15,000 to 25,000 mg+) - used in integrative medicine, requires G6PD testing first

What it costs

Standard immune drip with low-dose C: $150 to $250
Mid-dose dedicated vitamin C drip: $200 to $400
High-dose protocols (15,000 mg+): $300 to $600 per session
C push as an add-on: $25 to $75
Mobile premium: $50 to $100 on top

Safety considerations

G6PD deficiency - affects roughly 5% of the global population. Any clinic offering high-dose vitamin C should require this test before treatment.

Iron overload - vitamin C significantly increases iron absorption. Discuss with your physician if you have hemochromatosis.

Kidney stones - high doses can increase oxalate excretion. Consult your physician if you have a history of calcium oxalate kidney stones.

Where to find IV vitamin C

Almost every IV therapy clinic offers some level of vitamin C, usually as part of an immune support drip. Dedicated high-dose protocols are less common and typically require an integrative-medicine clinic.

Looking for IV vitamin C in your city? Browse immune support clinics → or take our 60-second matching quiz.

What IV vitamin C actually does (and what it doesn't)

Oral vitamin C runs into a hard biological ceiling. The intestinal transporter responsible for absorbing it (SVCT1) saturates at roughly 200 mg per dose, after which fractional absorption drops sharply and the excess is excreted in urine. Plasma saturates around 200 to 400 mg of daily intake in healthy adults. You cannot meaningfully push plasma concentrations higher by swallowing more pills.

Intravenous administration bypasses the gut entirely. Pharmacokinetic studies have shown that IV dosing can produce plasma concentrations 30 to 70 times higher than the maximum tolerated oral dose, and high-dose protocols can reach peak plasma concentrations over 10 mM, roughly two orders of magnitude above what oral supplementation can achieve.

That difference matters because it splits IV vitamin C into two clinically distinct use categories that often get blurred in marketing copy.

The first is wellness dosing, typically 1 to 25 grams per session, marketed for immune support, antioxidant function, post-cold recovery, post-travel rebound, and general "wellness." Be honest about the evidence here: in otherwise healthy adults, the clinical data supporting these specific immune and energy claims is thin. Most of what's sold as an "immune drip" is reasonable as a hydration plus high-dose micronutrient delivery, but the curative or preventive claims outpace the research.

The second is high-dose or oncology-adjunctive dosing, typically 25 to 100+ grams per session, administered in integrative oncology and research settings. The mechanistic case is stronger here. At pharmacologic plasma concentrations, vitamin C generates hydrogen peroxide selectively toxic to some tumor cells, and the Riordan IVC Protocol targets blood concentrations of 350 to 400 mg/dL post-infusion. Even with that signal, high-dose IV vitamin C is considered adjunctive, not curative, and is not a replacement for standard oncology care.

Typical doses and what they treat

Doses cluster into four practical tiers, and the difference between them is not just price. It's screening, monitoring, and clinical intent.

5 to 7.5 grams. The standard "immune drip" dose in wellness clinics. Generally well tolerated in healthy adults, runs in 30 to 45 minutes, and is often combined with B-complex, zinc, glutathione, or magnesium. Marketed for immune support, post-cold recovery, jetlag, hangover rebound, and pre-event wellness. Evidence for clinical benefit in healthy adults is modest, but the safety profile at this dose is favorable and most clinics offer it without extensive screening. Typical price: $150 to $250.

10 to 15 grams. A moderate dose marketed for active illness recovery, post-surgical healing support, intensive travel schedules, and athletes pushing through heavy training blocks. Sessions usually run 45 to 60 minutes. At this range, well-run clinics start asking more questions about kidney history and may begin requiring G6PD screening. Typical price: $200 to $350.

25 to 50 grams. A higher-dose protocol that requires G6PD blood screening before the first session and is usually administered in integrative or functional medicine settings rather than walk-in med spas. Sessions run 60 to 90 minutes with controlled drip rate. Marketed for chronic infection support, autoimmune-related fatigue, Lyme protocols, and as a step-up phase in oncology-adjunctive sequences. Typical price: $200 to $500 per session.

50 to 100+ grams. Research and oncology-adjunctive dosing. The Riordan protocol starts at roughly 15 g, escalates to 25 g and then 50 g over the first three sessions, and adjusts from there to hit target plasma concentrations. This tier requires extensive screening (G6PD, kidney function, baseline labs), close monitoring during infusion, and coordination with the patient's oncologist if cancer treatment is active. It is administered only at specialized integrative oncology clinics. Typical price: $400 to $1,000+ per session, usually as part of multi-session packages.

The critical patient takeaway: if a med spa is offering 50 g infusions without G6PD screening, that is not the same product as a 50 g infusion at an integrative oncology clinic. The dose on the bag is identical. The safety infrastructure around it is not.

Why G6PD screening is non-negotiable

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked enzyme deficiency affecting roughly 400 million people worldwide, with notably higher prevalence in people of African, Mediterranean, Middle Eastern, and South and Southeast Asian descent. Many people who carry it have no symptoms day to day and have never been tested.

The clinical problem with IV vitamin C is that high pharmacologic doses generate hydrogen peroxide as part of the mechanism that makes the therapy interesting in the first place. In a G6PD-deficient patient, red blood cells cannot adequately handle that oxidative load, and the result can be acute hemolytic anemia, a serious and occasionally fatal reaction. Most documented cases of hemolysis involve doses above 60 g, but the threshold for risk is not universally agreed on, which is why responsible clinics screen well below that.

The practical standard: any clinic administering doses above roughly 10 grams should require a G6PD blood test (lab cost typically $50 to $150) before the first high-dose session. The test is simple, results return in a few days, and it is the single most important safety step in this entire therapy.

A timing nuance worth knowing: G6PD testing during active hemolysis can produce falsely normal results because the surviving red cells skew younger and enzyme-replete. The test should be done at baseline, not after symptoms appear.

Patient responsibility is direct. Ask explicitly whether you've been screened. Get a copy of the result. Do not accept "we'll just start slow" or "we'll watch for symptoms" as a substitute for a lab test before high-dose dosing. That is a clinically dangerous corner to cut.

What IV vitamin C costs (2026 ranges)

US pricing in 2026 breaks into reasonably predictable tiers.

Add-on vitamin C boost (1 to 3 g added to a base hydration or Myers' drip): $25 to $75.
Standalone "immune drip" (5 to 15 g, often with B-complex, zinc, and glutathione): $150 to $300.
High-dose IV vitamin C (25 to 50 g, with G6PD screening required): $200 to $500 per session.
Oncology-adjunctive high-dose (50 to 100+ g, integrative oncology setting): $400 to $1,000+ per session, almost always sold as a multi-session protocol.

Mobile delivery adds $50 to $150 on top, covering the nurse's travel and the convenience of in-home or in-office administration.

Multi-session packages are common and usually discount per-session cost by 15 to 25 percent at the 5 to 10 session range. Be careful here: package pricing is a legitimate cost-saver for protocols you would have done anyway, and a sales tool when applied to wellness dosing you don't actually need a course of.

Insurance generally does not cover wellness IV vitamin C in the US. Some integrative oncology protocols may qualify for HSA or FSA reimbursement with a Letter of Medical Necessity from a prescribing physician; ask before assuming.

Geography matters meaningfully. New York, San Francisco, Los Angeles, and Miami tend to run 30 to 50 percent above the same service in Phoenix, Atlanta, Houston, or smaller metros, both for clinic and mobile delivery.

Side effects and contraindications

Most side effects are mild and manageable. The serious ones are predictable in patients who weren't properly screened.

Vein irritation at the insertion site. Common, mild, usually self-resolves within hours.
Nausea or lightheadedness during fast infusion. Common at higher doses, almost always fixable by slowing the drip rate.
Hemolytic anemia in G6PD-deficient patients. Rare when screening is enforced, serious when it isn't.
Kidney stone risk in patients with a history of oxalate stones. Vitamin C metabolizes partly to oxalate, and ascorbate contributes 30 to 50 percent of urinary oxalate. Repeated high doses can raise stone risk in susceptible patients.
Acute or chronic oxalate nephropathy following prolonged high-dose infusion in patients with pre-existing renal impairment.
Interference with chemotherapy drugs in active oncology patients. High-dose vitamin C must be coordinated with the treating oncologist, never run in parallel without disclosure.
Drug interactions with anticoagulants. Generally clinically minor, but worth disclosing on intake.

Contraindications include G6PD deficiency at high doses, severe kidney disease, a personal history of calcium oxalate kidney stones, and active cancer treatment without oncology coordination. Pregnancy is not a blanket contraindication: lower wellness doses are generally considered safe, but the decision should run through the patient's OB before booking.

Related on TheDripMap

How to choose a vitamin C IV provider

The bar is higher for vitamin C IV than for a basic hydration drip. Here is what to verify before you book, especially for any dose above 10 grams.

Medical director's name and state license, verifiable on the state medical board website.
An RN or ND performing the insert and monitoring the infusion, not an LPN or medical assistant.
Sourcing of ascorbic acid and IV bags from a sterile compounding pharmacy, registered as 503A or 503B with the FDA. Ask. A reputable clinic will answer without hesitation.
G6PD screening protocol for any dose above 10 grams, with documentation of the result before the first session.
A pre-session intake that covers kidney history, prior kidney stones, current medications, and any active cancer treatment.
Drip rate monitoring. High-dose vitamin C should run over 30 to 60 minutes at minimum, not pushed faster to free up the chair.
Clear pricing posted online without a high-pressure package upsell at the first visit.
Documented coordination with the patient's oncologist if the protocol is oncology-adjunctive. No exceptions.

Vitamin C IV done right is one of the better-tolerated infusions on a wellness menu, and at high doses it is one of the few wellness-adjacent therapies with a serious mechanistic and research footprint behind it. Done wrong, with skipped screening, an unlicensed administrator, or sub-therapeutic dosing dressed up as a clinical protocol, it is a wasted $200 at best and a preventable hospital visit at worst. The difference is almost entirely in the questions you ask before the needle goes in.